Cerebroprotective effect of sitagliptin and aminoguanidine combination in disorders of cerebral circulation

Cerebroprotective effect of sitagliptin and aminoguanidine combination in disorders of cerebral circulation

The aim of the study was to evaluate a cerebroprotective activity of the sitagliptin and aminoguanidine combination in rats with an acute and chronic cerebral circulation insufficiency, as well as with a traumatic brain injury.Materials and methods. The study was carried out on male Wistar rats in 3...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, Yu. V. Gorbunova, A. V. Strygin, T. M. Andriashvili, A. A. Sokolova, N. S. Bolokhov, V. E. Pustynnikov, E. A. Fomichev, A. V. Baskova, S. S. Polodyants, A. V. Kasparova
Format:	Article
Language:	Russian
Published:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2023-08-01
Series:	Фармация и фармакология (Пятигорск)
Subjects:	dpp-4 inhibitors sitagliptin preclinical studies acute and chronic cerebral circulation insufficiency traumatic brain injury
Online Access:	https://www.pharmpharm.ru/jour/article/view/1295
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HYPOGLYCEMIC EFFECT OF SITAGLIPTIN AND AMINOGUANIDINE COMBINATION IN EXPERIMENTAL DIABETES MELLITUS
by: D. V. Kurkin, et al.
Published: (2023-02-01)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

National Council of Experts: the place of DPP-4 inhibitors in the treatment of patients with type 2 diabetes mellitus
by: M. V. Shestakova, et al.
Published: (2023-12-01)

ASSESSMENT OF SITAGLIPTIN INFLUENCE ON ARTERIAL WALL STIFFNESS, RENAL FUNCTION AND RENAL CIRCULATION IN CARDIOVSCULAR PATIENTS WITH DECOMPENSATED TYPE 2 DIABETES
by: E. V. Oskola, et al.
Published: (2015-03-01)

Efficacy and safety of evogliptin versus sitagliptin as add on to metformin alone in a combined russian-korean population. Evo-combi trial
by: Alina Y. Babenko, et al.
Published: (2018-09-01)

Physiology, pharmacology and prospects for dipeptidilpeptidase-4 inhibitors use
by: D. V. Kurkin, et al.
Published: (2023-05-01)

Immunomodulatory Effect of Rivaroxaban Nanoparticles Alone and in Combination with Sitagliptin on Diabetic Rat Model
by: Mohamed M. Elbadr, et al.
Published: (2025-03-01)

The Impact of Sitagliptin on Sodium Valproate-Induced Autism in a Mouse Model
by: Ahmed Sudan Abbas, et al.
Published: (2024-09-01)

Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus
by: A. V. Simanenkova, et al.
Published: (2021-07-01)

Enhanced meropenem activity and stability following load in Polyvinyl alcohol nanofiber scaffolds with sitagliptin as quorum sensing inhibitor on Pseudomonas aeruginosa
by: Abdelrahman A. Mohsen, et al.
Published: (2025-08-01)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01)

Dipeptidyl peptidase-4 enzyme inhibition and its impacts on hepatic preneoplasia: a new avenue for liver cancer management
by: Hebatollah E. Eitah, et al.
Published: (2025-07-01)

Sitagliptin phosphate ameliorates chronic inflammation in diabetes mellitus via modulating macrophage polarization
by: Xiaoxia Hu, et al.
Published: (2025-04-01)

Type 2 diabetes mellitus in elderly patients treated with endocrinologists in clinical practice
by: Elena V. Biryukova
Published: (2019-12-01)

Correction of psychological and neurological signs of alcohol hangover in rats with acetylcysteine
by: D. V. Kurkin, et al.
Published: (2019-12-01)

Ocular and Plasma Pharmacokinetics of Sitagliptin Eye Drops: Preclinical Data
by: Cristina Hernández, et al.
Published: (2024-11-01)

Circulating Interleukin-22 Is a Biomarker for Newly Diagnosed Type 2 Diabetes Mellitus and Associated with Hypoglycemic Effect of Sitagliptin
by: Sun P, et al.
Published: (2025-03-01)

Dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin ameliorates inflammation and autophagy in mice hindlimb ischemia–reperfusion injury
by: Marwa Abdeltawab Mohammed, et al.
Published: (2024-12-01)

Comparing the effectiveness of pterostilbene and sitagliptin on modulating inflammatory levels and inducing autophagy to improve atherosclerosis outcome: A preclinical study in rabbits [version 4; peer review: 2 approved]
by: Wisam J Mohammed, et al.
Published: (2025-05-01)

Simultaneous Metformin and Sitagliptin Effect on Proteins Content Involved in Insulin Resistance in Human Adipose Tissue of Type 2 Diabetes: A Clinical Trial
by: Reza Didehdar, et al.
Published: (2025-07-01)

CORRECTION OF PSYCHONEUROLOGICAL SIGNS OF ACUTE ALCOHOL INTOXICATION IN RATS WITH A NEW ACETYLCYSTEINE-BASED COMPOSITION
by: D. V. Kurkin, et al.
Published: (2021-05-01)

In Vivo and Computational Studies on Sitagliptin’s Neuroprotective Role in Type 2 Diabetes Mellitus: Implications for Alzheimer’s Disease
by: Vasudevan Mani, et al.
Published: (2024-11-01)

Comparative assessment of treatment outcomes of empagliflozin add-on metformin and sitagliptin add-on metformin therapies in uncontrolled type 2 diabetes mellitus: findings from an observational study in Pakistan
by: Arif Ullah Khan, et al.
Published: (2025-08-01)

Metal-organic-framework-based sitagliptin-release platform for multieffective radiation-induced intestinal injury targeting therapy and intestinal flora protective capabilities
by: Dan He, et al.
Published: (2024-10-01)

Preclinical systematic review of CCR5 antagonists as cerebroprotective and stroke recovery enhancing agents
by: Ayni Sharif, et al.
Published: (2025-04-01)

Development and validation of a UPLC-MS/MS method for the simultaneous estimation of Ertugliflozin and Sitagliptin in bulk and tablet dosage forms: Assessment of greenness and blueness
by: Voohitha Manukonda, et al.
Published: (2025-03-01)

The effect of an aminoguanidine derivative on adjuvant arthritis in rats
by: V. S. Motov, et al.
Published: (2022-04-01)

The effect of empagliflozin and sitagliptin as an add-on therapy to metformin in blood pressure reduction in diabetic patients in primary health care settings in Riyadh, Saudi Arabia
by: Mayada Ahmed, et al.
Published: (2025-03-01)

Effectiveness assessment of sulfur-containing amino acids in rats with experimental “alcohol withdrawal syndrome” with modified zoosocial interaction methods
by: V. I. Petrov, et al.
Published: (2024-05-01)

Could Increased Glp1r Expression via Sitagliptin in the GLP-1/GLP-1 Receptor Axis in the DietInduced Obesity Rat Model be Important in Liver Metabolism?
by: Cem Horozoğlu, et al.
Published: (2024-12-01)

Development and Validation of a Highly Sensitive LC–MS/MS Method for the Precise Quantification of Sitagliptin in Human Plasma and Its Application to Pharmacokinetic Study
by: Yuna Song, et al.
Published: (2025-07-01)

Study on Anti-inflammatory and Anti-oxidative Stress Mechanism of Sitagliptin: a Dipeptidyl Peptidase-4 Inhibitor
by: ZHU Jing, XIE Ji, HU Xiaoxia
Published: (2025-04-01)

Comparison of the effects of empagliflozin and sitagliptin, as an add-on to metformin, on cardio-metabolic and glycemic parameters of patients with type 2 diabetes mellitus: a randomized, double-blind clinical trial
by: Naimeh Mesri Alamdari, et al.
Published: (2025-07-01)

Dipeptidyl peptidase-4 inhibitors: their role in the management of type 2 diabetes
by: Gail Mkele
Published: (2013-12-01)

Opportunities of cerebroprotection in children in cardiac surgery (review of literature)
by: A. A. Ivkin, et al.
Published: (2023-02-01)

UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4
by: T. V. Romanova, et al.
Published: (2018-06-01)

New plant agents with cerebroprotective effect
by: V. N. Burkova, et al.
Published: (2011-10-01)

Efficacy of Adding Sitagliptin to Ongoing Metformin on Metabolic Profile, Triglyceride-Glucose Index, Vitamin D3, and Liver Tests in Patients Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial
by: Habib Yaribeygi, PhD, et al.
Published: (2024-01-01)

Cerebroprotective prevention of memory disorders using sodium valproate
by: A. V. Ivanov
Published: (2013-04-01)

Cerebroprotective properties of nitric oxide in children in cardiac surgery (literature review)
by: K. S. Pevneva, et al.
Published: (2024-10-01)